We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 61-80 of 327 results
  1. Polypharmacology in Drug Design and Discovery—Basis for Rational Design of Multitarget Drugs

    Chapter 3 through Chap. 11 introduces the current status of clinical...
    Zhiguo Wang, Baofeng Yang in Polypharmacology
    Chapter 2022
  2. Monoclonal Antibodies: Past, Present and Future

    Monoclonal antibodies (mAbs) are immunoglobulins designed to target a specific epitope on an antigen. Immunoglobulins of identical amino-acid...
    J. Posner, P. Barrington, ... A. Datta-Mannan in Concepts and Principles of Pharmacology
    Chapter 2019
  3. Cancer Therapy

    This chapter comprehensively and systematically reviews the different modalities of anti-cancer therapies. Therapeutic options are classified into...
    Chapter 2019
  4. Monoclonal Antibodies in Cancer

    The development of hybridoma technology by Kohler and Milstein 1975 was a milestone in the development of monoclonal antibody technology. It was...
    Jürgen Barth in Pharmaceutical Biotechnology
    Chapter 2019
  5. Thermal/Electrical Injuries

    The skin is the primary barrier to the external insults an organism may encounter. It is a resilient and durable structure with many defense...
    Chapter 2018
  6. Neuroprotective Agents

    A pharmacological classification of various neuroprotective agents is shown in Table 2.1. Approximately 80 categories are listed and include examples...
    Protocol 2019
  7. Implantable neurotechnologies: electrical stimulation and applications

    Neural stimulation using injected electrical charge is widely used both in functional therapies and as an experimental tool for neuroscience...

    Sudip Nag, Nitish V. Thakor in Medical & Biological Engineering & Computing
    Article 11 January 2016
  8. Biocompatibility Testing: The Biologic Tests

    Most biocompatibility testing requirements are drawn from a common set of designs—from those guidelines called out by the ISO-10993-1 table. All...
    Chapter 2019
  9. Obesity and Endometrial Cancer: Mouse Models for Preclinical Prevention Studies

    Endometrial cancer risk is more strongly associated with obesity than any other cancer type and it is estimated that well over half of endometrial...
    Rosemarie E. Schmandt, Katherine A. Naff in Focus on Gynecologic Malignancies
    Chapter 2018
  10. Prospects of Natural Polymeric Scaffolds in Peripheral Nerve Tissue-Regeneration

    Tissue-engineering is emerging field and can be considered as a novel therapeutic intervention in nerve tissue-regeneration. The various pitfalls...
    Roqia Ashraf, Hasham S. Sofi, ... Faheem A. Sheikh in Novel Biomaterials for Regenerative Medicine
    Chapter 2018
  11. Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system

    It is widely recognized that myelination of axons greatly enhances the speed of signal transmission. An exciting new finding is the dynamic...

    Ileana Micu, Jason R. Plemel, ... Peter K. Stys in Nature Reviews Neuroscience
    Article 09 November 2017
  12. EpCAM-Independent Enrichment and Detection of Viable Circulating Tumor Cells Using the EPISPOT Assay

    Identification and characterization of circulating tumor cells (CTCs) in peripheral blood can provide information on the direction and the efficacy...
    Alexandra Soler, Laure Cayrefourcq, ... Catherine Alix-Panabières in Circulating Tumor Cells
    Protocol 2017
  13. Correction of neurogenesis in the adult brain: Selection of therapeutic targets

    Endogenous neurogenesis results in the formation of new neural structures that are prerequisites for numerous functions of the adult brain....

    O. A. Gomazkov in Neurochemical Journal
    Article 01 January 2017
  14. Current Therapies and Future Directions in Treatment of Glioblastoma

    The current standard of care for initial treatment of adults with newly diagnosed glioblastoma (GBM) constitutes maximal safe resection followed by...
    Joshua L. Wang, Luke Mugge, ... Vinay K. Puduvalli in Advances in Biology and Treatment of Glioblastoma
    Chapter 2017
  15. Nanointerventions for Gene Therapy

    Selective silencing of an over-expressed gene or constitutively expressing an under-expressed gene represents an effective strategy to treat diseases...
    K. Uma Maheswari, Vadim Annenkov in Gene and Cell Therapy: Biology and Applications
    Chapter 2018
  16. Neuroprotection in Miscellaneous Neurological Disorders

    Several neurological disorders that are not covered in the preceding chapters result in damage to the brain requiring neuroprotection. In addition to...
    Protocol 2019
Did you find what you were looking for? Share feedback.